ALB and brain cancer: One of the most widely used protein-based nanoformulations in the therapeutic studies of brain cancers involves the use of serum albumin, possibly due to the high energy/nutrient requirement-induced overexpression of albumin binding proteins (e.g., gp60) on cancerous cells [170,171].